This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
Why no Schedule of Assets here? DFE holdings often live on the master trust’s own audited statement, not as a 4i schedule on the participating plans’ filings. We’re extending the parsing pipeline to cover DFE filings — see Methodology.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $847K | — |
| KPMG LLP | 13-5565207 | — | NONE | $118K | — |
| MAPLES AND CALDER | — | — | NONE | $29K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $10K | — |
| T. ROWE PRICE ASSOCIATES, INC. | 52-0556948 | — | NONE | $10K | — |
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| Index Ventures VII LP | — | — | $6.2M | $28.0M | 18.5% | |
| Index Ventures Growth III | — | — | $8.1M | $25.7M | 17.0% | |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Accel London IV | — | — | $3.0M | $9.2M | 6.1% | |
| Mosaic Ventures I | — | — | $4.3M | $8.9M |
| 5.9% |
| Investindustrial VI LP | — | — | $5.9M | $7.0M | 4.7% |
| Advent International GPE VIII-H | — | — | $4.9M | $6.7M | 4.4% |
| QCP Feeder Fund SCSp | — | — | $3.3M | $6.6M | 4.4% |
| Altor Fund IV | — | — | $5.5M | $5.8M | 3.8% |
| Palamon European Equity III 'A' | — | — | $5.3M | $5.2M | 3.4% |
| MCP Private Capital Fund II | — | — | $4.0M | $5.1M | 3.4% |
| JPMorgan US Government Money Market Fund | — | — | $4.8M | $4.8M | 3.2% |
| TDR Capital III | — | — | $1.9M | $3.8M | 2.5% |
| Affinity Asia Pacific Fund IV | — | — | $3.5M | $3.6M | 2.4% |
| France Special Situations Fund II | — | — | $6.9M | $3.5M | 2.3% |
| Aleph | — | — | $2.0M | $3.5M | 2.3% |
| HitecVision VII | — | — | $6.0M | $3.4M | 2.2% |
| LeasePlan Corporation N.V. | — | — | $2.2M | $3.1M | 2.1% |
| Waterland Private Equity Fund VI C.V. | — | — | $2.4M | $3.0M | 2.0% |
| Oakley Capital Private Equity II-B | — | — | $3.3M | $2.5M | 1.7% |
| TDR Capital AS 2013 | — | — | — | $2.2M | 1.5% |
| Amoena Management Holdings GmbH | — | — | $1.8M | $1.7M | 1.1% |
| Latour Capital II | — | — | $11K | $1.6M | 1.1% |
| Harwood Private Equity IV | — | — | $1.4M | $1.6M | 1.1% |
| Vitruvian Investment Partnership II-B LP | — | — | $2.5M | $1.5M | 1.0% |
| ASP CIV | — | — | $397K | $1.3M | 0.8% |
| Nordic Capital VIII Beta | — | — | $2.9M | $980K | 0.6% |
| Xilos Co-Investment No. 1 Separate Limited | — | — | $858K | $903K | 0.6% |
| Crescent Capital Partners V | — | — | $497K | $728K | 0.5% |
| Eurazeo PME II | — | — | $1.6M | $528K | 0.3% |
| TDR Capital II | — | — | $1.5M | $306K | 0.2% |
| Affinity Asia Pacific Fund III | — | — | $4.4M | $240K | 0.2% |
| Quadrant Private Equity No.4 | — | — | $4K | $225K | 0.1% |
| Charterhouse Capital Partners IX | — | — | $2.4M | $28K | <0.1% |
| Pacific Equity Partners IV | — | — | $224K | $23K | <0.1% |
| Pacific Equity Partners Supplementary Fund IV | — | — | $69K | $9K | <0.1% |
| HitecVision SpringPoint LP 195 HitecVision V | — | — | $625K | $2K | <0.1% |
| HitecVision SpringPoint LP 0 | — | — | — | $2K | <0.1% |
